XML 50 R25.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Schedule II - Valuations and Qualifying Accounts | 12 Months Ended
--- | ---
Jun. 30, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] |
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] | Cardinal Health, Inc. and Subsidiaries Schedule II - Valuation and Qualifying Accounts
(in millions) | Balance at Beginning of Period |  | Charged to Costs and Expenses (1) |  | Charged to Other Accounts (2) |  | Deductions (3) |  | Balance at End of Period
Fiscal 2024 |  |  |  |  |  |  |  |  |
Accounts receivable | $ | 240 |  |  | $ | 108 |  |  | $ | — |  |  | $ | (115) |  |  | $ | 233 |
Finance notes receivable | 6 |  |  | 2 |  |  | — |  |  | (5) |  |  | 3 |
Sales returns and allowances | 474 |  |  | 2,207 |  |  | — |  |  | (2,240) |  |  | 441 |
| $ | 720 |  |  | $ | 2,317 |  |  | $ | — |  |  | $ | (2,360) |  |  | $ | 677 |
Fiscal 2023 |  |  |  |  |  |  |  |  |
Accounts receivable | $ | 207 |  |  | $ | 165 |  |  | $ | — |  |  | $ | (132) |  |  | $ | 240 |
Finance notes receivable | 8 |  |  | — |  |  | — |  |  | (2) |  |  | 6 |
Sales returns and allowances | 617 |  |  | 2,217 |  |  | — |  |  | (2,360) |  |  | 474 |
| $ | 832 |  |  | $ | 2,382 |  |  | $ | — |  |  | $ | (2,494) |  |  | $ | 720 |
Fiscal 2022 |  |  |  |  |  |  |  |  |
Accounts receivable | $ | 176 |  |  | $ | 109 |  |  | $ | 1 |  |  | $ | (79) |  |  | $ | 207 |
Finance notes receivable | 12 |  |  | 1 |  |  | — |  |  | (5) |  |  | 8 |
Sales returns and allowances | 689 |  |  | 2,359 |  |  | — |  |  | (2,431) |  |  | 617 |
| $ | 877 |  |  | $ | 2,469 |  |  | $ | 1 |  |  | $ | (2,515) |  |  | $ | 832 |
(1)Fiscal 2024, 2023 and 2022 accounts receivable operating earnings impacts include $74 million, $109 million and $87 million, respectively, for reserves related to service charges and customer disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss). (2)Recoveries of amounts provided for or written off in prior years were immaterial in fiscal 2024 and 2023 and $1 million in fiscal 2022. (3)Write-off of uncollectible accounts or actual sales returns. Amounts have been revised to reflect the correction of certain immaterial misstatements. Refer to Note 1 of the "Notes to Consolidated Financial Statements" for additional information. The sum of the components may not equal the total due to rounding.

X
- Definition The entire disclosure for valuation and qualifying accounts and reserves. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 09 -Publisher SEC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 4 -Subparagraph (SX 210.12-09) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4 + Details
Name: | srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | srt_ValuationAndQualifyingAccountsAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration